Contraceptive Devices Market Size & Share 2021 - Company Profiles, Upcoming Demand, and Forecast by Regions 2026

on

 According to the latest report by IMARC Group, titled “Contraceptive Devices Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026″, the global contraceptive devices market size exhibited moderate growth during 2015-2020.  Looking forward, IMARC Group expects the market to grow at a CAGR of 6.2% during 2021-2026. Contraceptive devices refer to birth control tools used to prevent pregnancies and sexually transmitted diseases (STDs). These devices are customized for both male and female users and comprise spermicides to chemically neutralize sperms. Condoms, diaphragms, sponges, cervical caps, vaginal rings, subdermal implants and intrauterine devices (IUD) are some of the commonly used contraceptive devices.

Request Free Sample Report: https://www.imarcgroup.com/contraceptive-devices-market/requestsample



Market Trends:

The rising prevalence of STDs, including chlamydia, hepatitis B, gonorrhea, trichomoniasis, HIV/AIDS, represents one of the significant factors strengthening the growth of the contraceptive devices market across the globe. Moreover, the growing consciousness among individuals about the available alternatives for minimizing unexpected pregnancies is catalyzing the demand for contraceptive devices. Furthermore, leading manufacturers are investing in research and development (R&D) activities to develop product variants with higher efficacy and minimal side-effects. This, in confluence with the increasing inclination toward delayed pregnancies and rising healthcare expenditures of individuals, is anticipated to fuel the market growth.

Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/contraceptive-devices-market

Key Market Segmentation:

Competitive Landscape with Key Player:

  • Allergan Plc
  • Bayer Healthcare
  • Church & Dwight Co. Inc.
  • Cooper Surgical Inc.
  • Merck & Co.
  • Mylan Laboratories
  • Pfizer Inc.
  • Reckitt Benckiser
  • Teva Pharmaceutical Industries Ltd.
  • The Female Health Company

Breakup by Device Type:

  • Condoms
  • Diaphragms
  • Cervical Caps
  • Sponges
  • Vaginal Rings
  • IUDs
  • Others

Breakup by End User:

  • Male
  • Female

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Stores
  • Others

Breakup by Application:

  • Household
  • Commercial
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key Highlights of the Report:

  • Market Performance (2015-2020)
  • Market Outlook (2021-2026)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Related Report:

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Comments

Post a Comment